Mar 1, 2026 Log in

News

Pao Ling Fu Chin Biotech Co., Ltd.: Q1 2026 EPS 0.60 NTD

Citation-Grade Primary-source linked Schema.org verified NQ 0 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 13, 2026 8:27 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Pao Ling Fu Chin Biotech Co., Ltd.
reported a stable performance in Q1 2026, with an EPS of 0.60 NTD, operating revenue of 519 million NTD, and net income after tax of 52 million NTD.
This reaffirms its position in the biotechnology and medical industry.

Pao Ling Fu Chin Biotech Co., Ltd. reported a stable performance in Q1 2026, with an EPS of 0.60 NTD, operating revenue of 519 million NTD, and net income after tax of 52 million NTD. This reaffirms its position in the biotechnology and medical industry.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: Mar 1, 2026

Company Code: 1760 Company Name: Pao Ling Fu Chin Biotech Co., Ltd. Industry: Biotechnology and Medical Industry Year/Quarter: Q1 2026 Basic Earnings Per Share (EPS): 0.60 NTD Operating Revenue: 519 million NTD Net Income After Tax: 52 million NTD

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　May 14, 2026 8:00 AM
AI structured & analyzed　May 14, 2026 8:29 AM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-1760-2026Q1

When was it published?

Mar 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“Pao Ling Fu Chin Biotech Co., Ltd.: Q1 2026 EPS 0.60 NTD”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.washinmura.jp/ai/%E5%AF%B6%E9%BD%A1%E5%AF%8C%E9%8C%A6%E7%94%9F%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-05-13-pao-ling-fu-chin-biotech-co-ltd-q1-2026

AI CRAWLER ACTIVITY

as of Jul 8, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4451k

last Jul 8, 2026

GPTBot

bot_visits_summary

3270k

last Jul 8, 2026

Bingbot

bot_visits_summary

2158k

last Jul 8, 2026

Applebot

bot_visits_summary

1919k

last Jul 8, 2026

Google AI

bot_visits_summary

1621k

last Jul 8, 2026

Googlebot

bot_visits_summary

1227k

last Jul 8, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 寶齡富錦生技股份有限公司 Back to newsroom (13)

Copied